Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
EXPONENT INC
Bear Case (25th pct.)
-57.7% vs price
Base Case (Median)
-47.8% vs price
Bull Case (75th pct.)
-38.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $39.72 | -41.0% | High (40%) |
| PE Comparable | $43.13 | -35.9% | Medium (25%) |
| Growth Trajectory DCF | $29.14 | -56.7% | Medium (20%) |
| Graham Number | $20.00 | -70.3% | High (80%) |
| EV/EBITDA | $35.13 | -47.8% | Medium (20%) |
| EV/FCF | $47.39 | -29.6% | Medium (20%) |
| Earnings Power Value | $27.84 | -58.6% | High (70%) |
Based on 7 out of 7 methods, EXPO appears overvalued at the current price of $67.30. The base case fair value of $35.13 implies 47.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.